Tecovirimat
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 495 publications
Mpox therapeutics in the post-STOMP/PALM era.
Journal: Current opinion in HIV and AIDS
Published: January 06, 2026
Removing barriers to tecovirimat treatment for individuals infected with mpox via a novel care delivery model.
Journal: JAAPA : official journal of the American Academy of Physician Assistants
Published: December 23, 2025
Characteristics of Inpatient Admission for Mpox Infection Control Isolation at 2 Large New York City Health Systems, 2022-2023.
Journal: Public health reports (Washington, D.C. : 1974)
Published: November 24, 2025
Synthesis of Antiviral Drug Tecovirimat and Its Key Maleimide Intermediates Using Organocatalytic Mumm Rearrangement at Ambient Conditions.
Journal: International journal of molecular sciences
Published: November 22, 2025
Maternal-Fetal Implications of Mpox Infection: Current Evidence.
Journal: Journal of clinical medicine
Published: November 22, 2025
Battle won, war ongoing: A call for mpox vaccination in high-risk dermatologic cases.
Journal: JAAD case reports
Published: November 14, 2025
Cutaneous Mpox: an epidemiological, clinical, diagnostic and therapeutic review of the dermatologic pandemic of the decade.
Journal: Italian journal of dermatology and venereology
Published: October 27, 2025
Combination of Mpox With Ocular Involvement, Human Immunodeficiency Virus, and Pulmonary Tuberculosis Resulting in High Mortality: A Report of Two Cases.
Journal: Cureus
Published: October 02, 2025
Ligand-based design and optimization of tecovirimat derivatives as potent antiviral agents against monkeypox virus.
Journal: European journal of medicinal chemistry
Published: September 15, 2025
Last Updated: 02/24/2026